RATIONALE: Heterogeneity in the septic response has hindered efforts to understand pathophysiology and develop targeted therapies. Source of infection, with different causative organisms and temporal changes, might influence this heterogeneity. OBJECTIVES: To investigate individual and temporal variations in the transcriptomic response to sepsis due to fecal peritonitis, and to compare these with the same parameters in community-acquired pneumonia. METHODS: We performed genome-wide gene expression profiling in peripheral blood leukocytes of adult patients admitted to intensive care with sepsis due to fecal peritonitis (n = 117) or community-acquired pneumonia (n = 126), and of control subjects without sepsis (n = 10). MEASUREMENTS AND MAIN RESULTS: A substantial portion of the transcribed genome (18%) was differentially expressed compared with that of control subjects, independent of source of infection, with eukaryotic initiation factor 2 signaling being the most enriched canonical pathway. We identified two sepsis response signature (SRS) subgroups in fecal peritonitis associated with early mortality (P = 0.01; hazard ratio, 4.78). We defined gene sets predictive of SRS group, and serial sampling demonstrated that subgroup membership is dynamic during intensive care unit admission. We found that SRS is the major predictor of transcriptomic variation; a small number of genes (n = 263) were differentially regulated according to the source of infection, enriched for IFN signaling and antigen presentation. We define temporal changes in gene expression from disease onset involving phagosome formation as well as natural killer cell and IL-3 signaling. CONCLUSIONS: The majority of the sepsis transcriptomic response is independent of the source of infection and includes signatures reflecting immune response state and prognosis. A modest number of genes show evidence of specificity. Our findings highlight opportunities for patient stratification and precision medicine in sepsis.
RATIONALE: Heterogeneity in the septic response has hindered efforts to understand pathophysiology and develop targeted therapies. Source of infection, with different causative organisms and temporal changes, might influence this heterogeneity. OBJECTIVES: To investigate individual and temporal variations in the transcriptomic response to sepsis due to fecal peritonitis, and to compare these with the same parameters in community-acquired pneumonia. METHODS: We performed genome-wide gene expression profiling in peripheral blood leukocytes of adult patients admitted to intensive care with sepsis due to fecal peritonitis (n = 117) or community-acquired pneumonia (n = 126), and of control subjects without sepsis (n = 10). MEASUREMENTS AND MAIN RESULTS: A substantial portion of the transcribed genome (18%) was differentially expressed compared with that of control subjects, independent of source of infection, with eukaryotic initiation factor 2 signaling being the most enriched canonical pathway. We identified two sepsis response signature (SRS) subgroups in fecal peritonitis associated with early mortality (P = 0.01; hazard ratio, 4.78). We defined gene sets predictive of SRS group, and serial sampling demonstrated that subgroup membership is dynamic during intensive care unit admission. We found that SRS is the major predictor of transcriptomic variation; a small number of genes (n = 263) were differentially regulated according to the source of infection, enriched for IFN signaling and antigen presentation. We define temporal changes in gene expression from disease onset involving phagosome formation as well as natural killer cell and IL-3 signaling. CONCLUSIONS: The majority of the sepsis transcriptomic response is independent of the source of infection and includes signatures reflecting immune response state and prognosis. A modest number of genes show evidence of specificity. Our findings highlight opportunities for patient stratification and precision medicine in sepsis.
Authors: Hector R Wong; Natalie Z Cvijanovich; Nick Anas; Geoffrey L Allen; Neal J Thomas; Michael T Bigham; Scott L Weiss; Julie Fitzgerald; Paul A Checchia; Keith Meyer; Thomas P Shanley; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J Freishtat; Jeffrey Nowak; Raj S Shekhar; Shira Gertz; Emily Dawson; Kelli Howard; Kelli Harmon; Eileen Beckman; Erin Frank; Christopher J Lindsell Journal: Am J Respir Crit Care Med Date: 2015-02-01 Impact factor: 21.405
Authors: Benjamin M P Tang; Anthony S McLean; Ian W Dawes; Stephen J Huang; Mark J Cowley; Ruby C Y Lin Journal: Crit Care Med Date: 2008-04 Impact factor: 7.598
Authors: Russell R Miller; Bert K Lopansri; John P Burke; Mitchell Levy; Steven Opal; Richard E Rothman; Franco R D'Alessio; Venkataramana K Sidhaye; Neil R Aggarwal; Robert Balk; Jared A Greenberg; Mark Yoder; Gourang Patel; Emily Gilbert; Majid Afshar; Jorge P Parada; Greg S Martin; Annette M Esper; Jordan A Kempker; Mangala Narasimhan; Adey Tsegaye; Stella Hahn; Paul Mayo; Tom van der Poll; Marcus J Schultz; Brendon P Scicluna; Peter Klein Klouwenberg; Antony Rapisarda; Therese A Seldon; Leo C McHugh; Thomas D Yager; Silvia Cermelli; Dayle Sampson; Victoria Rothwell; Richard Newman; Shruti Bhide; Brian A Fox; James T Kirk; Krupa Navalkar; Roy F Davis; Roslyn A Brandon; Richard B Brandon Journal: Am J Respir Crit Care Med Date: 2018-10-01 Impact factor: 21.405
Authors: Hector R Wong; Natalie Z Cvijanovich; Nick Anas; Geoffrey L Allen; Neal J Thomas; Michael T Bigham; Scott L Weiss; Julie C Fitzgerald; Paul A Checchia; Keith Meyer; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J Freishtat; Jeffrey Nowak; Riad Lutfi; Shira Gertz; Jocelyn R Grunwell; Christopher J Lindsell Journal: Crit Care Med Date: 2018-03 Impact factor: 7.598
Authors: Timothy E Sweeney; Tej D Azad; Michele Donato; Winston A Haynes; Thanneer M Perumal; Ricardo Henao; Jesús F Bermejo-Martin; Raquel Almansa; Eduardo Tamayo; Judith A Howrylak; Augustine Choi; Grant P Parnell; Benjamin Tang; Marshall Nichols; Christopher W Woods; Geoffrey S Ginsburg; Stephen F Kingsmore; Larsson Omberg; Lara M Mangravite; Hector R Wong; Ephraim L Tsalik; Raymond J Langley; Purvesh Khatri Journal: Crit Care Med Date: 2018-06 Impact factor: 7.598
Authors: Aleksandra Leligdowicz; Lauren F Chun; Alejandra Jauregui; Kathryn Vessel; Kathleen D Liu; Carolyn S Calfee; Michael A Matthay Journal: Am J Physiol Lung Cell Mol Physiol Date: 2018-07-19 Impact factor: 5.464
Authors: Hector R Wong; Timothy E Sweeney; Kimberly W Hart; Purvesh Khatri; Christopher J Lindsell Journal: Crit Care Med Date: 2017-12 Impact factor: 7.598